chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Illness, Mobility decreased
Clinical narrative: Was sick for three or four days after the vaccine; Pain in legs, arms; Pain in back of the neck; Can't lift arms / Hard to move in the mornings; Achy; Fever; Felt tired; Joint pains - Pain in the ligaments and shoulders; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Was sick for three or four days after the vaccine), PAIN IN EXTREMITY (Pain in legs, arms), NECK PAIN (Pain in back of the neck), MOBILITY DECREASED (Can't lift arms / Hard to move in the mornings) and PAIN (Achy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced ILLNESS (Was sick for three or four days after the vaccine), PAIN IN EXTREMITY (Pain in legs, arms), MOBILITY DECREASED (Can't lift arms / Hard to move in the mornings), PAIN (Achy), PYREXIA (Fever), FATIGUE (Felt tired), ARTHRALGIA (Joint pains - Pain in the ligaments and shoulders) and CHILLS (Chills). 25-Feb-2021, the patient experienced NECK PAIN (Pain in back of the neck). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 28-Feb-2021, ILLNESS (Was sick for three or four days after the vaccine) and FATIGUE (Felt tired) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in legs, arms), MOBILITY DECREASED (Can't lift arms / Hard to move in the mornings), PYREXIA (Fever), ARTHRALGIA (Joint pains - Pain in the ligaments and shoulders) and CHILLS (Chills) had not resolved and NECK PAIN (Pain in back of the neck) and PAIN (Achy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient has been seeing a doctor that works with trigger point needling. In the follow up it was reported that patients arms was almost spastic, cannot hold a cup first thing in the am, difficult to lift arms throughout the day and  difficult to dress, comb.   This case was linked to MOD-2021-028847 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up information received  contains non-significant information On 05-Jun-2021: Outcome of event updated, patient demographics added, concomitant medication added, event details added
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: Was sick for three or four days after the vaccine; Pain in legs, arms; Pain in back of the neck; Can't lift arms / Hard to move in the mornings; Achy; Fever; Felt tired; Joint pains - Pain in the ligaments and shoulders; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Was sick for three or four days after the vaccine), PAIN IN EXTREMITY (Pain in legs, arms), NECK PAIN (Pain in back of the neck), MOBILITY DECREASED (Can't lift arms / Hard to move in the mornings) and PAIN (Achy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced ILLNESS (Was sick for three or four days after the vaccine), PAIN IN EXTREMITY (Pain in legs, arms), MOBILITY DECREASED (Can't lift arms / Hard to move in the mornings), PAIN (Achy), PYREXIA (Fever), FATIGUE (Felt tired), ARTHRALGIA (Joint pains - Pain in the ligaments and shoulders) and CHILLS (Chills). 25-Feb-2021, the patient experienced NECK PAIN (Pain in back of the neck). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 28-Feb-2021, ILLNESS (Was sick for three or four days after the vaccine) and FATIGUE (Felt tired) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in legs, arms), MOBILITY DECREASED (Can't lift arms / Hard to move in the mornings), PYREXIA (Fever), ARTHRALGIA (Joint pains - Pain in the ligaments and shoulders) and CHILLS (Chills) had not resolved and NECK PAIN (Pain in back of the neck) and PAIN (Achy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient has been seeing a doctor that works with trigger point needling. In the follow up it was reported that patients arms was almost spastic, cannot hold a cup first thing in the am, difficult to lift arms throughout the day and  difficult to dress, comb.   This case was linked to MOD-2021-028847 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jun-2021: Follow-up information received  contains non-significant information On 05-Jun-2021: Outcome of event updated, patient demographics added, concomitant medication added, event details added
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Illness, Vaccination site rash
Clinical narrative: couldn't get up; kept on falling; rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site), ILLNESS (couldn't get up) and ASTHENIA (kept on falling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hypertension, Cholesterol, Parkinson's disease, Kidney stones, Breast cancer, Fibromyalgia, Arthritis, Osteoarthritis, Neuropathy and Acid reflux (esophageal). Concurrent medical conditions included Type II diabetes mellitus and Liver disorder (stage 4 liver disease). Concomitant products included GABAPENTIN, INSULIN GLARGINE (BASAGLAR), LISINOPRIL, CARBIDOPA, Levadopa, Omega fish oil, TRAMADOL, EZETIMIBE, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), Carbidopa ER and ALUMINIUM HYDROXIDE, DICYCLOVERINE HYDROCHLORIDE, MAGNESIUM OXIDUM LEVE (DICYCLOMINE CO) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE RASH (rash at the injection site). On an unknown date, the patient experienced ILLNESS (couldn't get up) and ASTHENIA (kept on falling). At the time of the report, VACCINATION SITE RASH (rash at the injection site), ILLNESS (couldn't get up) and ASTHENIA (kept on falling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication details was reported.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Deviation from recommended age group; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Deviation from recommended age group) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Deviation from recommended age group). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Deviation from recommended age group) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy rash on the arm where she was injected; Developed a small red, itchy rash on the arm where she was injected; A small red, itchy rash on the arm where she was injected; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy rash on the arm where she was injected), VACCINATION SITE RASH (Developed a small red, itchy rash on the arm where she was injected) and VACCINATION SITE ERYTHEMA (A small red, itchy rash on the arm where she was injected) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy rash on the arm where she was injected), VACCINATION SITE RASH (Developed a small red, itchy rash on the arm where she was injected) and VACCINATION SITE ERYTHEMA (A small red, itchy rash on the arm where she was injected). At the time of the report, VACCINATION SITE PRURITUS (Itchy rash on the arm where she was injected), VACCINATION SITE RASH (Developed a small red, itchy rash on the arm where she was injected) and VACCINATION SITE ERYTHEMA (A small red, itchy rash on the arm where she was injected) had not resolved.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Side effects from vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects from vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effects from vaccine). At the time of the report, ADVERSE EVENT (Side effects from vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Headache; body aches; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), NAUSEA (Nausea), HEADACHE (headache) and MYALGIA (body aches) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036a21a) for COVID-19 vaccination.  No Medical History information was reported.  On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced VOMITING (vomiting), NAUSEA (Nausea) and HEADACHE (headache). On an unknown date, the patient experienced MYALGIA (body aches). On 09-Mar-2021, VOMITING (vomiting), NAUSEA (Nausea) and HEADACHE (headache) had resolved. At the time of the report, MYALGIA (body aches) outcome was unknown.     No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-068382 (Linked Report).  Sender's Comments: MOD-2021-068382:Second dose case
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Extremely itchy, sore; Lump on collarbone; Lump on left arm; extremely itchy, sore; Lump on left arm; extremely itchy, sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Extremely itchy, sore), LYMPHADENOPATHY (Lump on collarbone), VACCINATION SITE SWELLING (Lump on left arm; extremely itchy, sore) and VACCINATION SITE PAIN (Lump on left arm; extremely itchy, sore) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Extremely itchy, sore), LYMPHADENOPATHY (Lump on collarbone), VACCINATION SITE SWELLING (Lump on left arm; extremely itchy, sore) and VACCINATION SITE PAIN (Lump on left arm; extremely itchy, sore). At the time of the report, VACCINATION SITE PRURITUS (Extremely itchy, sore), LYMPHADENOPATHY (Lump on collarbone), VACCINATION SITE SWELLING (Lump on left arm; extremely itchy, sore) and VACCINATION SITE PAIN (Lump on left arm; extremely itchy, sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: Sore arm; 17 year old daughter received the 1st dose; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old daughter received the 1st dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 023C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old daughter received the 1st dose). On 31-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old daughter received the 1st dose) had resolved. On 02-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: On 24-MAY-2021, ADR form attached, Patient demographics was updated, product details of dose #1 was added.
Sex: U
Vaccine: COVID19
Symptoms: Accidental exposure to product, Incorrect dose administered
Clinical narrative: If more than half of the dose or if less than half of the dose was administered; Vaccine went into eyes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INCORRECT DOSE ADMINISTERED (If more than half of the dose or if less than half of the dose was administered) and ACCIDENTAL EXPOSURE TO PRODUCT (Vaccine went into eyes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history and concomitant drug information was provided by reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (If more than half of the dose or if less than half of the dose was administered) and ACCIDENTAL EXPOSURE TO PRODUCT (Vaccine went into eyes). At the time of the report, INCORRECT DOSE ADMINISTERED (If more than half of the dose or if less than half of the dose was administered) and ACCIDENTAL EXPOSURE TO PRODUCT (Vaccine went into eyes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No medical history and concomitant drug information was reported by reporter. No treatment medication was provided by reporter.   This case was linked to MOD21-070696 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Follow-up information received on 06-APR-2021 contains no significant information. On 26-Jun-2021: Follow-up information received on 26-JUN-2021 contains contact information of immunization center was updated.; Sender's Comments:  MOD21-070696:CROSS LINK
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Needle stick and full dose was not administered to patient; Needle stick and full dose was not administered to patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Needle stick and full dose was not administered to patient) and DEVICE CONNECTION ISSUE (Needle stick and full dose was not administered to patient) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (Needle stick and full dose was not administered to patient) and DEVICE CONNECTION ISSUE (Needle stick and full dose was not administered to patient). At the time of the report, UNDERDOSE (Needle stick and full dose was not administered to patient) and DEVICE CONNECTION ISSUE (Needle stick and full dose was not administered to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was specified.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: Body ache; Headache; This spontaneous case was reported by a pharmacist and describes the occurrence of MYALGIA (Body ache) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced MYALGIA (Body ache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MYALGIA (Body ache) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.    This case was linked to MOD-2021-068385 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vomiting
Clinical narrative: Vomiting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and VOMITING (Vomiting) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced HEADACHE (Headache). On 05-Apr-2021, the patient experienced VOMITING (Vomiting). At the time of the report, HEADACHE (Headache) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Itchy hives all over body; Itchy hives all over body; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Itchy hives all over body) and PRURITUS (Itchy hives all over body) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BAYER ASPIRIN), HYDROCHLOROTHIAZIDE and MELOXICAM for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced URTICARIA (Itchy hives all over body) and PRURITUS (Itchy hives all over body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Itchy hives all over body) and PRURITUS (Itchy hives all over body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication including vitamins was reported.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Crepitations, Dizziness, Erythema, Headache
Clinical narrative: A clicking sensation and a popping sensation with range of motion in the right arm; Right shoulder pain; Slight nausea; Headache; Slight dizziness; Redness over his right upper arm; This spontaneous case was reported by a nurse and describes the occurrence of CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm), DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), ARTHRALGIA (Right shoulder pain) and NAUSEA (Slight nausea) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), NAUSEA (Slight nausea) and HEADACHE (Headache). On an unknown date, the patient experienced CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm) and ARTHRALGIA (Right shoulder pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm), DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), ARTHRALGIA (Right shoulder pain), NAUSEA (Slight nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: A clicking sensation and a popping sensation with range of motion in the right arm; Right shoulder pain; Slight nausea; Headache; Slight dizziness; Redness over his right upper arm; This spontaneous case was reported by a nurse and describes the occurrence of CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm), DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), ARTHRALGIA (Right shoulder pain) and NAUSEA (Slight nausea) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), NAUSEA (Slight nausea) and HEADACHE (Headache). On an unknown date, the patient experienced CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm) and ARTHRALGIA (Right shoulder pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, CREPITATIONS (A clicking sensation and a popping sensation with range of motion in the right arm), DIZZINESS (Slight dizziness), ERYTHEMA (Redness over his right upper arm), ARTHRALGIA (Right shoulder pain), NAUSEA (Slight nausea) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, SARS-CoV-2 test
Clinical narrative: Not feeling good; Positive for covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive for covid-19) and FEELING ABNORMAL (Not feeling good) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Positive for covid-19). On an unknown date, the patient experienced FEELING ABNORMAL (Not feeling good). At the time of the report, COVID-19 (Positive for covid-19) and FEELING ABNORMAL (Not feeling good) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, SARS-CoV-2 test: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-068650 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068650:husband case
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Myalgia, Nausea
Clinical narrative: Aches in both her legs; Feeling real bad; Body aches; Nausea; Headache; Vomiting; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Aches in both her legs), FEELING ABNORMAL (Feeling real bad), MYALGIA (Body aches), NAUSEA (Nausea) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017b21a and 036a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (Aches in both her legs), FEELING ABNORMAL (Feeling real bad), MYALGIA (Body aches), NAUSEA (Nausea), HEADACHE (Headache), VOMITING (Vomiting) and FATIGUE (Exhausted). At the time of the report, PAIN IN EXTREMITY (Aches in both her legs), FEELING ABNORMAL (Feeling real bad), MYALGIA (Body aches), NAUSEA (Nausea), HEADACHE (Headache), VOMITING (Vomiting) and FATIGUE (Exhausted) was resolving.            The  concomitant medications on use were not provided.  No treatment information was provided.     This case was linked to MOD-2021-068369 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: Aches in both her legs; Feeling real bad; Body aches; Nausea; Headache; Vomiting; Exhausted; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Aches in both her legs), FEELING ABNORMAL (Feeling real bad), MYALGIA (Body aches), NAUSEA (Nausea) and HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017b21a and 036a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced PAIN IN EXTREMITY (Aches in both her legs), FEELING ABNORMAL (Feeling real bad), MYALGIA (Body aches), NAUSEA (Nausea), HEADACHE (Headache), VOMITING (Vomiting) and FATIGUE (Exhausted). At the time of the report, PAIN IN EXTREMITY (Aches in both her legs), FEELING ABNORMAL (Feeling real bad), MYALGIA (Body aches), NAUSEA (Nausea), HEADACHE (Headache), VOMITING (Vomiting) and FATIGUE (Exhausted) was resolving.            The  concomitant medications on use were not provided.  No treatment information was provided.     This case was linked to MOD-2021-068369 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Myalgia, Pyrexia
Clinical narrative: Felt wiped out; Fever; Chills; Aches and pains; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt wiped out), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Aches and pains) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in May 2020 and Convalescent plasma transfusion (Convalescent plasma therapy).   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt wiped out), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Aches and pains). At the time of the report, FEELING ABNORMAL (Felt wiped out), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Aches and pains) outcome was unknown.            Concomitant medications were not reported.  No treatment information was specified.   This case was linked to MOD-2021-071109 (Patient Link).
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Myalgia
Clinical narrative: Nose bleed; Body ache; This spontaneous case was reported by a pharmacist and describes the occurrence of EPISTAXIS (Nose bleed) and MYALGIA (Body ache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 001A21A) for COVID-19 vaccination.     The patient's past medical history included Rhinoplasty. Concurrent medical conditions included Nose bleed.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced EPISTAXIS (Nose bleed) and MYALGIA (Body ache). At the time of the report, EPISTAXIS (Nose bleed) and MYALGIA (Body ache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided.  The patient took Ibuprofen as treatment medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-068376 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068376:CROSSLINKED WITH DOSE 1
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Feeling hot
Clinical narrative: dizzy; couldn't sleep Saturday night; once or twice felt really hot; joint pain; nauseous; on and off chills still happening; tired; possible fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain) and NAUSEA (nauseous) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B2HA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain), NAUSEA (nauseous), CHILLS (on and off chills still happening), FATIGUE (tired) and PYREXIA (possible fever). At the time of the report, DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain), NAUSEA (nauseous), CHILLS (on and off chills still happening), FATIGUE (tired) and PYREXIA (possible fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information for the events was provided.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Pyrexia
Clinical narrative: dizzy; couldn't sleep Saturday night; once or twice felt really hot; joint pain; nauseous; on and off chills still happening; tired; possible fever; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain) and NAUSEA (nauseous) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B2HA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain), NAUSEA (nauseous), CHILLS (on and off chills still happening), FATIGUE (tired) and PYREXIA (possible fever). At the time of the report, DIZZINESS (dizzy), INSOMNIA (couldn't sleep Saturday night), FEELING HOT (once or twice felt really hot), ARTHRALGIA (joint pain), NAUSEA (nauseous), CHILLS (on and off chills still happening), FATIGUE (tired) and PYREXIA (possible fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information for the events was provided.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Pyrexia, SARS-CoV-2 test
Clinical narrative: weakness; fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) and PYREXIA (fever) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced ASTHENIA (weakness) and PYREXIA (fever). At the time of the report, ASTHENIA (weakness) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.  No concomitant medications provided by Reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Retching, Vaccination site bruising
Clinical narrative: arm hurt strongly; Arm was bruised; dry heaving; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt strongly), VACCINATION SITE BRUISING (Arm was bruised) and RETCHING (dry heaving) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESTRADIOL for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt strongly), VACCINATION SITE BRUISING (Arm was bruised) and RETCHING (dry heaving). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm hurt strongly) and VACCINATION SITE BRUISING (Arm was bruised) had resolved and RETCHING (dry heaving) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. The patient did not receive any treatment. Lab details were not provided.   This case was linked to MOD-2021-068406, MOD-2021-068406 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow up received on 17 MAY 2021, Reporter details added and contact information added.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Bloody nose; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Bloody nose) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included Thyroid disorder and Fibromyalgia.   On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced EPISTAXIS (Bloody nose). At the time of the report, EPISTAXIS (Bloody nose) outcome was unknown.            Concomitant medications included medications for thyroid and fibromyalgia.  No treatment details were provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Hyperhidrosis, Pain
Clinical narrative: Bad body ache; Sweating; fever-101; Bad chills; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Bad body ache), HYPERHIDROSIS (Sweating), PYREXIA (fever-101), CHILLS (Bad chills) and FATIGUE (Fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 12L200) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Bad body ache), HYPERHIDROSIS (Sweating), PYREXIA (fever-101) and FATIGUE (Fatigue). 05-Mar-2021, the patient experienced CHILLS (Bad chills). At the time of the report, PAIN (Bad body ache), HYPERHIDROSIS (Sweating), PYREXIA (fever-101), CHILLS (Bad chills) and FATIGUE (Fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 101.         Concomitant medications taken by the patient were not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-024145, US-MODERNATX, INC.-MOD-2021-023982, US-MODERNATX, INC.-MOD-2021-068189 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-024145:hushand first dose case US-MODERNATX, INC.-MOD-2021-023982:wife (First dose case) US-MODERNATX, INC.-MOD-2021-068189:wife (second dose case)
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Bad body ache; Sweating; fever-101; Bad chills; Fatigue; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Bad body ache), HYPERHIDROSIS (Sweating), PYREXIA (fever-101), CHILLS (Bad chills) and FATIGUE (Fatigue) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 12L200) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN (Bad body ache), HYPERHIDROSIS (Sweating), PYREXIA (fever-101) and FATIGUE (Fatigue). 05-Mar-2021, the patient experienced CHILLS (Bad chills). At the time of the report, PAIN (Bad body ache), HYPERHIDROSIS (Sweating), PYREXIA (fever-101), CHILLS (Bad chills) and FATIGUE (Fatigue) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 101.         Concomitant medications taken by the patient were not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-024145, US-MODERNATX, INC.-MOD-2021-023982, US-MODERNATX, INC.-MOD-2021-068189 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-024145:hushand first dose case US-MODERNATX, INC.-MOD-2021-023982:wife (First dose case) US-MODERNATX, INC.-MOD-2021-068189:wife (second dose case)
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: flu-like symptoms; fatigue; pain at the injection site; bled a lot after they gave him the injection; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE HAEMORRHAGE (bled a lot after they gave him the injection) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (bled a lot after they gave him the injection) (seriousness criterion medically significant). On 24-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE HAEMORRHAGE (bled a lot after they gave him the injection), INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medications were not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nausea, Pruritus, Rash, Vomiting
Clinical narrative: itchy but no pain; Got spacey; Feels lousy; Rash on right arm that looks like Excema; nauseous; vommitting; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy but no pain), FEELING ABNORMAL (Got spacey), FEELING ABNORMAL (Feels lousy), RASH (Rash on right arm that looks like Excema) and NAUSEA (nauseous) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Colitis, Lyme's disease, Immunocompromised and Babesiosis. Concomitant products included LOPERAMIDE HYDROCHLORIDE (LOMOTIL [LOPERAMIDE HYDROCHLORIDE]), CITALOPRAM, TRAZODONE, DOXYCYCLINE and VITAMIN 15 for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PRURITUS (itchy but no pain), FEELING ABNORMAL (Got spacey), FEELING ABNORMAL (Feels lousy), RASH (Rash on right arm that looks like Excema), NAUSEA (nauseous) and VOMITING (vommitting). At the time of the report, PRURITUS (itchy but no pain), FEELING ABNORMAL (Got spacey), FEELING ABNORMAL (Feels lousy), RASH (Rash on right arm that looks like Excema) and NAUSEA (nauseous) had not resolved and VOMITING (vommitting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-069958 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Event outcome updated as ongoing, additional event lousy is updated. Patient gender updated from unknown to female.; Sender's Comments:  MOD21-069958: